Alkindi has been approved by the US FDA as an alternative therapy for the treatment of children under 17 years of age with adrenal insufficiency (AI).
This is the first and only hydrocortisone pellet approved by the FDA for the treatment of children with AI. This is an oral, immediate-release granular formulation of hydrocortisone.
Active ingredient: hydrocortisone
0.5 Mg, 1 Mg, 2 Mg, 5 Mg